Planned procurement · Notice 107075-2026
PME for Tissue and Cell Management System
- Value
- £375k
- Stage
- Early notice
- Where
- London
- Lots
- 1
- Suitable for SMEs
- Yes, says the buyer
- Contract
- 3 May 2027 – 2 May 2032
In plain English
King's College Hospital NHS Foundation Trust is running early market engagement, not an open tender, to find suppliers of a tissue and cell management system for its stem cell transplant and cellular therapy laboratory in London. The current contract period is shown as 3 May 2027 to 2 May 2032, with an estimated value of £375,000, and the Trust expects a formal procurement to follow.
Good fit for: Healthcare software suppliers with a laboratory tissue and cell tracking system, ideally one already used in UK hospitals.
- Must meet HTA licensing and FACT-JACIE standards
enable the service to meet Human Tissue Authority (HTA) licensing requirements and FACT-JACIE accreditation standards
- Supplier must support system validation before go-live
Supplier support for installation, operational and performance qualification (IQ/OQ/PQ) will be required before go-live
- Must meet strict electronic record and data integrity standards
meet electronic record and traceability requirements under GAMP 5, GMP Annex 11 (Computerised Systems) and 21 CFR Part 11
Written with AI. Always bid from the official notice.
What the buyer says
King's College Hospital NHS Foundation Trust ("the Trust") is carrying out preliminary market engagement under the Procurement Act 2023 to understand the solutions available for a tissue and cell management system supporting its stem cell transplantation and cellular therapy laboratory services. The Trust currently uses a commercial off-the-shelf tissue and cell management system, in live use since 2023. The infrastructure on which it runs reaches end of support in January 2027, and the Trust is assessing its options for continuity of service from 2027. These include upgrading or migrating the existing solution and adopting an alternative solution. The purpose of this engagement is to establish which providers of this type of system exist in the market, and their level of interest, to help the Trust decide on the most appropriate route to market and timescales. The outcome will inform the Trust's requirements, options appraisal and business case, and the Trust anticipates that it will be followed by a formal procurement. The Trust is seeking solutions that provide end-to-end management and traceability of cellular therapy products, from donor and patient registration through collection, processing, cryopreservation, storage, issue and administration. The solution will need to support: • labelling and traceability in line with ICCBBA ISBT 128 standards; • a complete and secure audit trail; • quality management, including deviations and non-conformances; • inventory and storage location management; and • reporting. The solution will need to enable the service to meet Human Tissue Authority (HTA) licensing requirements and FACT-JACIE accreditation standards. It should also meet electronic record and traceability requirements under GAMP 5, GMP Annex 11 (Computerised Systems…
What happens next
This is an early notice: the buyer is planning a tender, and its documents come when the tender is published. Read the official notice for the details.
Procedure: not stated. Published 11 Nov 2026.
Similar open tenders
- Penetration Testing · Senedd Cymru / Welsh Parliament · closes 24 Nov
- Network Managed Service Provision (NMSP) · Corporate Officer of the House of Lords · closes 24 Nov
- CCHA 0328 Legal Services Framework for Land and Development · Castles and Coasts · closes 24 Nov
- Control of Contractors Portal · Transport for Wales Rail Limited (Utility Buyer) · closes 24 Nov
- Client-Side Advisor · SONI Ltd · closes 25 Nov
Want tenders like this, matched to your firm?
Winnable emails the few new tenders that fit you each weekday, with the catch spelled out. £29/month after a 14-day free trial (no card needed).